Expertise in
13
conditions

Wei Y. Yao

399 Wanyuan Road, 
Shanghai, CN 
Expertise in
13
conditions
399 Wanyuan Road, 
Shanghai, CN 

Overview

Wei Yao practices practicing medicine in Shanghai, China.

Yao is highly rated in 13 conditions, according to our data. Their clinical expertise encompasses Hemangioma Thrombocytopenia Syndrome, Kaposiform Hemangioendothelioma, Hemangioendothelioma, Nephrectomy, and Endoscopy.

They are actively involved in clinical research, co-authoring 105 peer reviewed articles and participating in 2 clinical trials.

Locations

399 Wanyuan Road, Shanghai, 201102, China
Other Locations
399 Wan Yuan Road, Shanghai, 201102, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangioendothelioma: a Randomized Controlled Trial
Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangioendothelioma: a Randomized Controlled Trial
Enrollment Status: Completed
Publish Date: September 26, 2023
Intervention Type: Drug
Study Drug: Sirolimus
Study Phase: Phase 4
Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma:A Prospective, Randomized Open Trial
Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma:A Prospective, Randomized Open Trial
Enrollment Status: Completed
Publish Date: January 30, 2023
Intervention Type: Drug
Study Drug: Sirolimus
Study Phase: Phase 4
View 1 Less Clinical Trial

105 Total Publications

Development and Validation of a SHAP-Interpretable Machine Learning Model for Stroke Risk Prediction Using Circulating MicroRNA Biomarkers.
Development and Validation of a SHAP-Interpretable Machine Learning Model for Stroke Risk Prediction Using Circulating MicroRNA Biomarkers.
Journal: Journal of molecular neuroscience : MN
Published: April 07, 2026

Frequently Asked Questions about Wei Y. Yao

Is Wei Y. Yao a top-rated expert for Hemangioma Thrombocytopenia Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Wei Y. Yao is classified as an Elite expert for Hemangioma Thrombocytopenia Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Wei Y. Yao participate in research or clinical trials?

Yes. Wei Y. Yao has published 105 articles and abstracts on conditions like Hemangioma Thrombocytopenia Syndrome. You can view a list of Wei Y. Yao's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Yao's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 29 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile